Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing
OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152